Literature DB >> 3229762

Serum concentrations and accumulation of silver in skin during three months treatment with an anti-smoking chewing gum containing silver acetate.

E J Jensen1, J Rungby, J C Hansen, E Schmidt, B Pedersen, R Dahl.   

Abstract

Silver acetate chewing gum was used for 12 weeks as a smoking deterrent in 21 adults. The effect of silver on serum concentrations, its accumulation in the skin and the risk of developing clinically evident argyria were investigated. Serum concentrations of silver clearly rose after chewing gum use had started, and concentrations quickly returned to normal after use had ceased. In most cases the number of silver granules in skin biopsies, observed by autometallography, increased after the gum had been used for 12 weeks. No one developed clinical signs of argyria. Silver acetate containing remedies can be used as an aid to stop smoking, but the consumption must be monitored to avoid accumulation of larger amounts of silver in the body.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229762     DOI: 10.1177/096032718800700603

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  4 in total

1.  Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation.

Authors:  E J Jensen; E Schmidt; B Pedersen; R Dahl
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

Review 2.  Cigarette smoking, nicotine dependence, and treatment.

Authors:  K L Sees
Journal:  West J Med       Date:  1990-05

3.  Involvement of thiols in the induction of inward current induced by silver in frog skeletal muscle membrane.

Authors:  T Aoki; K Nihonyanagi; T Oba
Journal:  Experientia       Date:  1993-09-15

4.  Short term serum pharmacokinetics of diammine silver fluoride after oral application.

Authors:  Elsa Vasquez; Graciela Zegarra; Edgar Chirinos; Jorge L Castillo; Donald R Taves; Gene E Watson; Russell Dills; Lloyd L Mancl; Peter Milgrom
Journal:  BMC Oral Health       Date:  2012-12-31       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.